DonaldPLawrenceMD

Clinical Trials

• Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

  Withdrawn

  Not Applicable

• Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2009 Jul 02

  Completed

  Phase 2

• Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma Start of enrollment: 2009 Jan 23

  Completed

  Phase 2

• Selumetinib in Cancers With BRAF Mutations Start of enrollment: 2009 Jul 01

  Completed

  Phase 2

• STA-9090(Ganetespib) in Metastatic Ocular Melanoma Start of enrollment: 2010 Sep 17

  Completed

  Phase 2

• Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma Start of enrollment: 2011 Nov 01

  Completed

  Phase 2

• Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma Start of enrollment: 2013 Aug 01

  Terminated

  Phase 2

• ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) Start of enrollment: 2019 Aug 20

  Recruiting

  Phase 1

  Roles: Contact, Principal Investigator

• ITIL-168 in Advanced Melanoma Start of enrollment: 2021 Oct 07

  Terminated

  Phase 2

  Roles: Principal Investigator

• A Study to Investigate LYL845 in Adults With Solid Tumors Start of enrollment: 2022 Dec 19

  Recruiting

  Phase 1

  Roles: Contact

• Join now to see all